Henry Schein (NASDAQ:HSIC) issued an update on its FY 2019 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $3.38-3.50 for the period, compared to the Thomson Reuters consensus estimate of $3.43. Henry Schein also updated its FY19 guidance to $3.38-3.50 EPS.
A number of equities research analysts have weighed in on the company. Wolfe Research assumed coverage on Henry Schein in a research note on Thursday. They issued an underperform rating for the company. Svb Leerink reaffirmed a market perform rating and set a $70.00 price objective (down previously from $75.00) on shares of Henry Schein in a report on Wednesday, May 15th. Leerink Swann lowered Henry Schein from an outperform rating to a market perform rating and dropped their price objective for the stock from $75.00 to $70.00 in a report on Wednesday, May 15th. They noted that the move was a valuation call. Zacks Investment Research lowered Henry Schein from a buy rating to a hold rating in a report on Tuesday, May 14th. Finally, Barrington Research upped their target price on Henry Schein from $72.00 to $75.00 and gave the company an outperform rating in a report on Wednesday, May 8th. Seven investment analysts have rated the stock with a sell rating, nine have given a hold rating and four have given a buy rating to the stock. Henry Schein has an average rating of Hold and an average price target of $74.27.
Shares of HSIC stock traded down $0.24 during trading hours on Thursday, reaching $65.13. The company had a trading volume of 899,425 shares, compared to its average volume of 1,812,958. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.93 and a current ratio of 1.65. Henry Schein has a twelve month low of $56.58 and a twelve month high of $91.35. The firm has a market cap of $9.71 billion, a P/E ratio of 15.77, a price-to-earnings-growth ratio of 2.32 and a beta of 0.89.
In other news, Director Philip A. Laskawy sold 1,084 shares of Henry Schein stock in a transaction that occurred on Tuesday, March 12th. The stock was sold at an average price of $59.86, for a total value of $64,888.24. Following the completion of the transaction, the director now owns 32,899 shares in the company, valued at approximately $1,969,334.14. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 1.06% of the stock is owned by company insiders.
ILLEGAL ACTIVITY WARNING: “Henry Schein (NASDAQ:HSIC) Issues FY 2019 Earnings Guidance” was first published by Rockland Register and is owned by of Rockland Register. If you are reading this article on another publication, it was stolen and republished in violation of United States and international copyright & trademark legislation. The legal version of this article can be accessed at https://rocklandregister.com/2019/05/31/henry-schein-hsic-issues-fy-2019-earnings-guidance.html.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Further Reading: How much can an individual set aside as a catch-up contribution?
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.